Therefore, TR-CD4 promoted survival and proliferation of tumor-specific CD8+ T cells through direct recognition of cancer cells, which could support long-term anti-tumor effect of CD8+ T cells at the local tumor site. This evidence concerns the gene CD8A and cancer.